Highlights Abbott Laboratories Swiss Exchange

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:35:38 2026-08-27 EDT			5-day change	1st Jan Change
90.50 ^CHF	-2.69%		-2.69%	-8.59%

08-27	Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing	MT
08-27	Abbott Laboratories' Stroke Treatment Device Receives CE Mark	MT

Highlights

08-25	Abbott Receives Fda Authorization for Libre Duo 10 Day Dual Glucose-Ketone Sensing Technology	CI
08-25	Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor	MT
08-25	FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients	RE
08-20	Abbott to pay $670 million to settle some preterm infant formula cases	RE
08-20	Abbott Reaches $670 Million Settlement Over Infant Formula Claims	MT
08-20	Abbott to Pay $670 Million to Settle Baby-Formula Litigation	DJ
08-20	Abbott reaches agreements to resolve portion of litigation over infant formula	RE
08-20	Healthtab Ltd and Abbott Enter Multi-Year Collaboration Agreement for Point-Of-Care Testing Across the Uk	CI
08-11	Abbott and Google Launch First-of-its-Kind Partnership to Transform Everyday Health Through Glucose Insights and AI	CI
07-28	Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on October 16, 2024.	CI
07-24	Abbott defeats shareholder lawsuit over 2022 infant formula recall	RE
07-24	Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall	RE
07-17	Abbott investigates two separate cyber incidents, says no operations affected	RE
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
07-16	Abbott Laboratories Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-16	Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views	MT
07-16	Abbott Laboratories 2Q Sales Rise on Diagnostics Growth	DJ
07-16	Abbott raises its 2026 adjusted EPS target range
07-16	Abbott Laboratories Q2 Adjusted Earnings, Revenue Rise; Raises 2026 Earnings Guidance	MT
07-16	(ABT) Abbott Laboratories Expects Q3 Adjusted EPS Range $1.38 - $1.46	MT
07-16	(ABT) Abbott Laboratories Expects 2026 Adjusted EPS Range $5.45 to $5.60, vs. FactSet Est of $5.47	MT
07-16	Earnings Flash (ABT) Abbott Laboratories Reports Q2 Revenue $12.59B, vs. FactSet Est of $12.52B	MT
07-16	Earnings Flash (ABT) Abbott Laboratories Posts Q2 Adjusted EPS $1.31 per Share	MT
07-02	Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula	RE
06-29	PRESS DIGEST-Wall Street Journal - June 29	RE